Eric Kelsic, Ph.D.
Eric Kelsic, PhD, is CEO and cofounder of Dyno Therapeutics, a VC-backed biotech located in Cambridge, Massachusetts. Dyno is a pioneer in applying artificial intelligence to gene therapy. Eric co-developed the technology underlying Dyno’s capsid engineering platform in George Church’s lab at the Wyss Institute of Harvard Medical School. He holds a PhD in Systems Biology from Harvard University and a BS in Physics from Caltech.